 |
 |
 |
 |
 |
 |
 |
 |
-
BROWSE TOPICS IN CLINICAL MANAGEMENT:
Antiretroviral Therapy- Complications of HIV/HAART
- Research & Development
- Clinical Trials
- Quality of Life & Patient Care
Antiretroviral Therapy
Pre-Exposure Prophylaxis
Overview
- CDC Trials of Daily Oral Tenofovir for Preventing HIV Infection (December 7, 2005)
To read PDF, click here
From U.S. Centers for Disease Control and Prevention - CDC's Clinical Studies of Daily Oral Tenofovir for HIV Prevention (June 2005)
Available only in PDF.
From U.S. Centers for Disease Control and Prevention
News & Research
- New Frontiers in HIV Prevention: Male Circumcision and Pre-Exposure Prophylaxis in the United States -- An Interview at CROI 2007 With Patrick Sullivan, Ph.D., and Lynn Paxton, M.D., M.P.H. (February 27, 2007)
In Exclusive Coverage of the 14th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - HIV Clinical Trial Aiming to Increase Participation of Black MSM (January 11, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Antiretroviral Drugs as Prevention Tools: PEP, PrEP and Prevention for Positives (September 27, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy - PrEP Studies Show Possible Effectiveness; Scientists Say Further Tests Must Be Completed for Confirmation (August 14, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Some MSM Already Using Tenofovir as Method of HIV Prevention, Outside of Clinical Trials (December 19, 2005)
Physicians and HIV prevention experts say tenofovir has been sold in gay dance clubs around the country and prescribed by some physicians for prevention.
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Family Health International Will Seek Support From Gates Foundation for Tenofovir Trials to Prevent HIV (August 5, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Antiretroviral Drug Researchers, AIDS Advocates Fail to Reach Consensus Over Viread Trials in Developing Countries (May 24, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Fact Sheet on "Project T": A Safety Study of Daily Oral Tenofovir to Prevent HIV Infection in HIV-Negative Men Who Have Sex With Men (PDF) (December 2004)
Study sites are in San Francisco and Atlanta.
From San Francisco Department of Public Health - Cambodian Sex Workers Refuse to Participate in Tenofovir HIV Prevention Trial (March 30, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - "It's OK, I'm on the AIDS Pill" (February 26, 2004)
Tenofovir (Viread) is being tested as a "morning-after" pill to prevent HIV infection. But if it's found to work, could it cause more problems than it solves?.
In Wired News - Prevention: New Approach Will Test Tenofovir for Persons at High Risk (November 22, 2002)
A brief analysis of the study's significance for women.
In AIDS Treatment News, from AIDS Treatment News - $6.5M Set Aside to Study Tenofovir as HIV-Prevention Pill (November 5, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
  |
  |